Feature Channels: Vision

Filters close
Released: 2-May-2023 1:50 PM EDT
Got Retinal Disease? Retina Specialists’ Unique Imaging Tools Can Help Preserve Vision
American Society of Retina Specialists

Advances in early detection and treatment of retinal diseases made possible by retina specialists can preserve sight and virtually eliminate vision loss from conditions such as age-related macular degeneration (AMD), diabetic retinopathy and retinal detachment.

Released: 2-May-2023 1:20 PM EDT
Press Registration for the ASRS 2023 Annual Scientific Meeting Now Open
American Society of Retina Specialists

The American Society of Retina Specialists (ASRS) invites members of the press to cover the latest advances in retina science and practice during its 41st Annual Scientific Meeting July 28 – August 1.

Released: 1-May-2023 6:05 PM EDT
Scientists discover anatomical changes in the brains of the newly sighted
Massachusetts Institute of Technology (MIT)

In a new study, Sinha and his colleagues have now discovered anatomical changes that occur in the brains of these patients after their sight is restored. These changes, seen in the structure and organization of the brain’s white matter, appear to underlie some of the visual improvements that the researchers also observed in these patients.

Released: 1-May-2023 3:35 PM EDT
Youth value eyesight but face key barriers to getting eyeglasses
Michigan Medicine - University of Michigan

Uncorrected refractive error—or, simply needing eyeglasses—is the main cause of visual impairment in United States youth. A lack of glasses leads to decreased school and work performance and worse overall health and wellbeing. And now, research shows that a few key barriers stop young people from getting the glasses they need.

Released: 1-May-2023 1:15 PM EDT
Researchers explore why some people get motion sick playing VR games while others don’t
University of Waterloo

The way our senses adjust while playing high-intensity virtual reality games plays a critical role in understanding why some people experience severe cybersickness and others don’t.

Newswise: Herpes study adds to understanding of viral reinfections, how to potentially prevent them
Released: 1-May-2023 10:25 AM EDT
Herpes study adds to understanding of viral reinfections, how to potentially prevent them
University of Illinois Chicago

A new study on herpes infections of the eye helps shed light on the question of viral reinfections by identifying a key protein involved in viral reinfections that could be targeted by antiviral drugs.

Newswise: King Chulalongkorn Memorial Hospital Doctors Suggest Ways to Prevent Glaucoma through Early Detection
Released: 28-Apr-2023 8:55 AM EDT
King Chulalongkorn Memorial Hospital Doctors Suggest Ways to Prevent Glaucoma through Early Detection
Chulalongkorn University

The Excellence Center for Glaucoma, Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, and Thai Glaucoma Society encourage all of us to realize the significance of glaucoma as it is the world’s number 1 cause of irreversible blindness. In Thailand, over 2 million people are affected by glaucoma.

Released: 27-Apr-2023 2:35 PM EDT
ChatGPT scores nearly 50 per cent on board certification practice test for ophthalmology, study shows
St. Michael's Hospital

A study of ChatGPT found the artificial intelligence tool answered less than half of the test questions correctly from a study resource commonly used by physicians when preparing for board certification in ophthalmology.

   
Newswise: Toward a Therapy for a Rare Genetic Disease
Released: 26-Apr-2023 1:05 PM EDT
Toward a Therapy for a Rare Genetic Disease
Harvard Medical School

Researchers design “mini gene” therapy for severe syndrome that causes blindness and deafness

Released: 25-Apr-2023 6:05 PM EDT
Precision eye therapy for dogs ready for human clinical development
Michigan State University

A successful gene therapy trialed at Michigan State University in dogs with an inherited eye disease is ready to be developed for clinical use in human patients with a rare condition called retinitis pigmentosa.

Newswise: Mudskippers Could Be Key to Understanding Evolution of Blinking
Released: 24-Apr-2023 5:05 PM EDT
Mudskippers Could Be Key to Understanding Evolution of Blinking
Georgia Institute of Technology

Blinking is crucial for the eye. It’s how animals clean their eyes, protect them, and even communicate. But how and why did blinking originate? Researchers at the Georgia Institute of Technology, Seton Hill University, and Pennsylvania State University studied the mudskipper, an amphibious fish that spends most of its day on land, to better understand why blinking is a fundamental behavior for life on land.

23-Apr-2023 6:00 AM EDT
Research to Prevent Blindness Announces New Sight-Saving Vision Research Grants
Research to Prevent Blindness

Research to Prevent Blindness (RPB) announces two new grants to support high-impact vision research. The new grants are the: RPB / Tom Wertheimer Career Development Award in Data Science and RPB / Mary Tyler Moore Vision Initiative Physician-Scientist Award.

Newswise:Video Embedded live-event-for-april-21-sleeping-pill-reduces-levels-of-alzheimer-s-proteins
VIDEO
Released: 21-Apr-2023 3:10 PM EDT
TRANSCRIPT AND VIDEO AVAILABLE Live Event for April 21: Sleeping pill reduces levels of Alzheimer’s proteins
Newswise

Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.

       
Newswise: Engineering the Next Generation of Cell and Gene Therapies
Released: 20-Apr-2023 4:20 PM EDT
Engineering the Next Generation of Cell and Gene Therapies
Cedars-Sinai

Cedars-Sinai investigators are developing a novel way to treat amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa using engineered stem cells that may eventually lead to personalized treatments.

Newswise: A renewable, engineered cell product shows potential for treating neurodegenerative and retinal diseases
Released: 20-Apr-2023 4:10 PM EDT
A renewable, engineered cell product shows potential for treating neurodegenerative and retinal diseases
International Society for Stem Cell Research

While strategies for regenerating or replacing lost neurons from stem cells are being developed, an alternative treatment option is the protection of existing neurons to prevent their degeneration, a recent study published in Stem Cell Reports suggests.

Newswise: Hungry eyes: Spiders lose vision when they're starving
Released: 20-Apr-2023 4:05 PM EDT
Hungry eyes: Spiders lose vision when they're starving
University of Cincinnati

Biologists at the University of Cincinnati discovered that underfed jumping spiders lose light-sensitive cells that are key to their vision.

   
Released: 18-Apr-2023 3:25 PM EDT
Treating dry age-related macular degeneration: 6 things to know
Michigan Medicine - University of Michigan

Do you have questions about treatment of age-related macular degeneration, otherwise known as dry AMD? Anjali Rajesh Shah, MD, ophthalmologist, an at Michigan Medicine, has answers.

Released: 17-Apr-2023 8:05 AM EDT
ARVO Foundation announces winner of 2023 Ludwig von Sallmann Clinician-Scientist Award
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) announced today that Patrick Yu-Wai-Man, MD, PhD (University of Cambridge, U.K.), is the 2023 recipient of the Ludwig von Sallmann Clinician-Scientist Award.

Newswise: Eye-opening Origin Story: Scientists Trace Key Innovation in Our Camera-like Vision to Bacteria
Released: 13-Apr-2023 3:25 PM EDT
Eye-opening Origin Story: Scientists Trace Key Innovation in Our Camera-like Vision to Bacteria
University of California San Diego

Scientists have traced the origin of a unique protein key to vertebrate’s camera-like vision back 500 million years. Their analysis of more than 900 genomes across the tree of life revealed that the protein came through horizontal gene transfer from foreign bacterial genes.

Released: 11-Apr-2023 3:20 PM EDT
Longer shelf life for insulin has major bearing on global health
University of Gothenburg

An international study shows that it is likely that insulin can be stored at room temperature, and for considerably longer than drug companies have counted on to date. Access to this vital medicine can thereby be significantly improved for the world’s poorest inhabitants. Researchers at the University of Gothenburg are among the scientists presenting these results.

Newswise: Retinal microvasculature is a potential biomarker for acute mountain sickness
Released: 7-Apr-2023 7:25 PM EDT
Retinal microvasculature is a potential biomarker for acute mountain sickness
Science China Press

This study is led by Dr.Ningli Wang and Dr.Yuan Xie (Beijing Tongren Hospital, Capital Medical University), they provide evidence that retinal microvasculature is a potential biomarker for cerebral microvasculature changes and acute mountain sickness(AMS) development during risk assessment of individuals at high altitudes.

Newswise: Monell Center Receives Funding for First-of-its-Kind Conference to Establish Universal Chemosensory Testing
Released: 3-Apr-2023 10:05 AM EDT
Monell Center Receives Funding for First-of-its-Kind Conference to Establish Universal Chemosensory Testing
Monell Chemical Senses Center

The Monell Chemical Senses Center, with colleagues from Massachusetts General Hospital, The Ohio State University, and University of Florida, has received funding from the NIH Institute on Deafness and Other Communication Disorders to organize a visionary conference titled, “Towards Universal Chemosensory Testing.” The overarching goal is to involve multiple stakeholders to develop strategies for implementing routine chemosensory testing - smell, taste, and related senses - across the lifespan as a part of US healthcare.

Newswise: Extremely rare gene variants point to a potential cause of age-related macular degeneration
29-Mar-2023 2:00 PM EDT
Extremely rare gene variants point to a potential cause of age-related macular degeneration
NIH, National Eye Institute (NEI)

A study from the National Eye Institute (NEI) identified rare genetic variants that could point to one of the general mechanisms driving age-related macular degeneration (AMD), a common cause of vision loss in older adults.

Newswise: March Research Highlights
Released: 31-Mar-2023 7:25 PM EDT
March Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news happening at Cedars-Sinai in March 2023.

Released: 31-Mar-2023 3:15 PM EDT
American Society of Retina Specialists’ Journal of Vitreoretinal Diseases Granted Indexing in PubMed Central
American Society of Retina Specialists

The American Society of Retina Specialists (ASRS) is pleased to announce that its official peer-reviewed scientific journal, Journal of VitreoRetinal Diseases (JVRD), has been granted indexing in PubMed Central (PMC).

Newswise: FDA-approved drug shows promise in lab models for blinding childhood disease 
Released: 29-Mar-2023 12:05 PM EDT
FDA-approved drug shows promise in lab models for blinding childhood disease 
NIH, National Eye Institute (NEI)

A National Eye Institute-led team has identified a compound already approved by the U.S. Food and Drug Administration that keeps light-sensitive photoreceptors alive in three models of Leber congenital amaurosis type 10 (LCA 10), an inherited retinal ciliopathy disease that often results in severe visual impairment or blindness in early childhood.

Released: 28-Mar-2023 5:20 PM EDT
Retinal scans: A non-invasive, inexpensive method to track human aging
Buck Institute for Research on Aging

Buck Institute professor Pankaj Kapahi thinks the eye is a window to aging. His lab, in collaboration with Google Health and Zuckerberg San Francisco General Hospital, has shown how imaging of the fundus, the blood vessel-rich tissue in the retina, can be used to track human aging, in a way that is noninvasive, less expensive and more accurate than other aging clocks that are currently available.

20-Mar-2023 9:00 AM EDT
New form of omega-3 could prevent visual decline with Alzheimer’s disease
American Society for Biochemistry and Molecular Biology (ASBMB)

For the first time, researchers have developed a form of the omega-3 fatty acid docosahexaenoic acid (DHA) that is capable of crossing into the eye’s retina to ward off visual declines related to Alzheimer’s disease, diabetes and other disorders.

Newswise: Early study shows cones in retinal degeneration, thought to be dormant, may retain visual function
Released: 27-Mar-2023 5:40 PM EDT
Early study shows cones in retinal degeneration, thought to be dormant, may retain visual function
University of California, Los Angeles (UCLA), Health Sciences

New UCLA research in mice suggests that “dormant” cone photoreceptors in the degenerating retina are not dormant at all, but continue to function, producing responses to light and driving retinal activity for vision.

Newswise: Eye color genes are critical for retinal health
Released: 24-Mar-2023 3:40 PM EDT
Eye color genes are critical for retinal health
Max Planck Institute of Molecular Cell Biology and Genetics

Metabolic pathways consist of a series of biochemical reactions in cells that convert a starting component into other products. There is growing evidence that metabolic pathways coupled with external stress factors influence the health of cells and tissues.

Newswise: Tiny nanoparticle could have big impact on patients receiving corneal transplants
Released: 24-Mar-2023 3:25 PM EDT
Tiny nanoparticle could have big impact on patients receiving corneal transplants
Virginia Commonwealth University (VCU)

Corneal transplants can be the last step to returning clear vision to many patients suffering from eye disease. Each year, approximately 80,000 corneal transplantations take place in the U.S. Worldwide, more than 184,000 corneal transplantation surgeries are performed annually.

   
22-Mar-2023 9:00 AM EDT
Vision Research Funding Partnership Event Takes Place Today
Research to Prevent Blindness

Today, Research to Prevent Blindness (RPB) and more than 30 other organizations are convening in Washington DC for the Vision Research Funding Partnership event, which was organized around the theme of “The Research Pipeline – From Premise to Patient.”

Released: 22-Mar-2023 2:50 PM EDT
Cataract surgery reimbursements may not be enough for some patients
Michigan Medicine - University of Michigan

Research suggests that Medicare reimbursements for complex cataract surgery cover less than two minutes of operating time, and an increase to reimbursements for the procedure may be justified. Complex cataract surgery requires more time and resources than simple cataract surgery, and this study indicates that the incremental reimbursement for the complex surgery is not enough to offset the increased costs.

Released: 22-Mar-2023 12:10 PM EDT
UCLA Health Tip Sheet: Visual loss and mask-wearing practices; Influenza vaccination rates are low; Mixed ancestry study provides clues to genetic traits
University of California, Los Angeles (UCLA), Health Sciences

Below is a brief roundup of news and story ideas from the experts at UCLA Health. For more information on these stories or for help on other stories, please contact us at [email protected].

Newswise: Effective treatment in rare but deadly form of cancer
Released: 21-Mar-2023 2:05 PM EDT
Effective treatment in rare but deadly form of cancer
University of Gothenburg

An advanced surgical therapy has proved considerably more efficacious than conventional treatments for patients with melanoma in the eye (uveal) that has spread to the liver, a University of Gothenburg study shows.

Newswise: Patients with family history of age-related macular degeneration should be screened by 55
Released: 21-Mar-2023 10:05 AM EDT
Patients with family history of age-related macular degeneration should be screened by 55
UT Southwestern Medical Center

Patients with a family history of age-related macular degeneration (AMD), the leading cause of permanent vision loss in those older than 60, should visit an ophthalmologist by age 55 to be screened for signs of the disease, advises an expert at UT Southwestern Medical Center.

Released: 20-Mar-2023 9:00 AM EDT
Antibiotic resistance is an increasing problem. Learn all about it in the Drug Resistance channel.
Newswise

Staphylococcus aureus, Clostridioides difficile, Candida auris, Drug-resistant Shigella. These bacteria not only have difficult names to pronounce, but they are also difficult to fight off. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Antimicrobial resistance is an urgent global public health threat.

     
Newswise: 新的基因编辑技术成功地逆转小鼠的视力损失
13-Mar-2023 9:55 AM EDT
新的基因编辑技术成功地逆转小鼠的视力损失
The Rockefeller University Press

视网膜色素变性症是人类失明的主要原因之一。中国的研究人员成功地恢复了患有视网膜色素变性症的小鼠的视力。该研究将于[三月十七日]发表在《实验医学杂志》上。该研究使用一种新型的、高度通用的CRISPR基因组编辑技术,有潜力纠正各种导致疾病的遗传突变。

Newswise: New gene-editing technique reverses vision loss in mice
13-Mar-2023 9:55 AM EDT
New gene-editing technique reverses vision loss in mice
The Rockefeller University Press

Researchers in China have successfully restored the vision of mice with retinitis pigmentosa, one of the major causes of blindness in humans. The study, to be published March 17 in the Journal of Experimental Medicine, uses a new, highly versatile form of CRISPR-based genome editing with the potential to correct a wide variety of disease-causing genetic mutations.

Newswise: Visually navigating on foot uses unique brain region
Released: 15-Mar-2023 8:45 AM EDT
Visually navigating on foot uses unique brain region
NIH, National Eye Institute (NEI)

Using vision to efficiently move through an area by foot uses a unique region of the brain’s cortex, according to a small study funded by the National Eye Institute (NEI).

Newswise: AI-based systems can help identify rapidly advancing age-related macular degeneration
Released: 14-Mar-2023 3:35 PM EDT
AI-based systems can help identify rapidly advancing age-related macular degeneration
NIH, National Eye Institute (NEI)

Researchers supported by the National Eye Institute are developing artificial intelligence/machine learning (AI/ML)-based systems that not only screen for AMD but also predict which patients will likely progress to late within two years. The systems also evaluate separately one’s risk for developing late wet (neovascular) AMD from one’s risk for late dry (geographic atrophy) AMD.

Newswise: The 2023 Shaffer Grants for Innovative Glaucoma Research
Released: 14-Mar-2023 1:30 PM EDT
The 2023 Shaffer Grants for Innovative Glaucoma Research
Glaucoma Research Foundation

Shaffer Grants provide seed funds to bold investigators whose creative projects explore promising leads and show strong potential for impact on glaucoma.

Released: 9-Mar-2023 11:55 AM EST
Stuart Therapeutics, Inc. Announces Upcoming Presentations at ARVO 2023 Annual Meeting
Stuart Therapeutics

Stuart Therapeutics, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for the treatment of anterior segment, refractive and posterior segment eye disorders, today announced that it is sponsoring two research poster presentations by researchers at Vanderbilt University and the University of Rochester at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, which will take place from April 23-27, 2023, in New Orleans, Louisiana.

   
Newswise: New Insights: Eye Damage in Alzheimer’s Disease Patients
Released: 3-Mar-2023 10:05 AM EST
New Insights: Eye Damage in Alzheimer’s Disease Patients
Cedars-Sinai

Cedars-Sinai investigators have produced the most extensive analysis to date of changes in the retina—a layer of tissue at the back of the eye where visual information originates—and how those retinal changes correspond to brain and cognitive changes in Alzheimer’s disease patients.

Newswise: Smart contact lens with navigation function, made with 3D printer!
Released: 2-Mar-2023 7:30 PM EST
Smart contact lens with navigation function, made with 3D printer!
National Research Council of Science and Technology

Dr. Seol Seung-Kwon's team at the Korea Electrotechnology Research Institute published in international journals, implementing augmented reality by meniscus-guided printing.

Newswise: See clearly with these tips for safely using eye drops
Released: 2-Mar-2023 1:35 PM EST
See clearly with these tips for safely using eye drops
Michigan Medicine - University of Michigan

What should you consider when choosing the best kind of artificial tears for your eyes?

Newswise: Eye experts weigh in on artificial tears in midst of infectious outbreak
Released: 2-Mar-2023 1:15 PM EST
Eye experts weigh in on artificial tears in midst of infectious outbreak
NIH, National Eye Institute (NEI)

Questions remain about artificial tears linked to an outbreak of Pseudomonas aeruginosa infections involving 64 people in 13 states, including 8 cases of vision loss, as well as lung and urinary tract infections, and one death. Federal agencies warned people to stop using EzriCare and Delsam Pharma artificial tears after tests of opened bottles used by those affected found a rare, extensively drug-resistant strain of P. aeruginosa. The strain had never been reported in the United States.What is clear is that eye health experts have advice for people using artificial tears, which are sold over the counter and widely used for eye irritation associated with dry eye disease, contact lens use, and refractive surgery, as well among those using other eye drops regularly, such as for glaucoma.

Newswise: How Common is Face Blindness?
Released: 27-Feb-2023 12:05 PM EST
How Common is Face Blindness?
Harvard Medical School

Face blindness, a mystifying condition that can trick us into believing we recognize people we’ve never met or make us fail to recognize those we have, has been previously estimated to affect between 2 and 2.5 percent of people in the world. Now, a new study by researchers at Harvard Medical School (HMS) and the VA Boston Healthcare System is providing fresh insights into the disorder, suggesting it may be more common than currently believed.



close
1.89166